Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303
      QxMD      Google Scholar   
Citation:
Blood Adv vol 7 (18) 5524-5539
Year:
2023
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
epub-ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
13
Parents:
3834  
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
Celgene  
Grants:
U10CA180821, U10CA180882; U24CA196171; U24CA237719, K22CA188163; K99HG007940; P30CA91842; R00HG007940; T32HL007088; U01CA209936; U01CA231844; U01CA248235, UG1CA189824, UG1CA233339  
Corr. Author:
 
Authors:
                                               
Networks:
FL028, LAPS-MN026, LAPS-MO011, NY018   
Study
Alliance-A151303
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-50402, CALGB-50701, CALGB-50803
Phases:
N/A, 2
Keywords:
Lymphoid Neoplasia